These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35083972)

  • 1. Early discontinuation of biological therapy among inflammatory bowel disease patients in Bahrain: Real world experience.
    Abdulla M; AlQamish J; Mohammed N; Al Saeed M; Al Aali HJ; Al Khaja A; Hasan ZAIY; Haider FY; Ebrahim SDN; Mahfoodh ZSA; Hubail MAH; Alhajri I; Al-Matrook F; Tork A
    Saudi J Gastroenterol; 2022; 28(3):193-200. PubMed ID: 35083972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis and prediction of nutritional outcome of patients with pediatric inflammatory bowel disease from Bahrain.
    Isa HM; Mohamed M; Alsaei A; Isa Z; Khedr E; Mohamed A; Jahrami H
    BMC Pediatr; 2024 Apr; 24(1):265. PubMed ID: 38658864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil.
    Sassaki LY; Miszputen SJ; Kaiser Junior RL; Catapani WR; Bafutto M; Scotton AS; Zaltman C; Baima JP; Ramos HS; Faria MAG; Gonçalves CD; Guimaraes IM; Flores C; Amarante HMBS; Nones RB; Parente JML; Lima MM; Chebli JM; Ferrari MLA; Campos JF; Sanna MGP; Ramos O; Parra RS; da Rocha JJR; Feres O; Feitosa MR; Caratin RF; Senra JT; Santana GO
    World J Gastroenterol; 2021 Jun; 27(23):3396-3412. PubMed ID: 34163120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
    Casanova MJ; Chaparro M; García-Sánchez V; Nantes O; Leo E; Rojas-Feria M; Jauregui-Amezaga A; García-López S; Huguet JM; Arguelles-Arias F; Aicart M; Marín-Jiménez I; Gómez-García M; Muñoz F; Esteve M; Bujanda L; Cortés X; Tosca J; Pineda JR; Mañosa M; Llaó J; Guardiola J; Pérez-Martínez I; Muñoz C; González-Lama Y; Hinojosa J; Vázquez JM; Martinez-Montiel MP; Rodríguez GE; Pajares R; García-Sepulcre MF; Hernández-Martínez A; Pérez-Calle JL; Beltrán B; Busquets D; Ramos L; Bermejo F; Barrio J; Barreiro-de Acosta M; Roncedo O; Calvet X; Hervías D; Gomollón F; Domínguez-Antonaya M; Alcaín G; Sicilia B; Dueñas C; Gutiérrez A; Lorente-Poyatos R; Domínguez M; Khorrami S; Muñoz C; Taxonera C; Rodríguez-Pérez A; Ponferrada A; Van Domselaar M; Arias-Rivera ML; Merino O; Castro E; Marrero JM; Martín-Arranz M; Botella B; Fernández-Salazar L; Monfort D; Opio V; García-Herola A; Menacho M; Ramírez-de la Piscina P; Ceballos D; Almela P; Navarro-Llavat M; Robles-Alonso V; Vega-López AB; Moraleja I; Novella MT; Castaño-Milla C; Sánchez-Torres A; Benítez JM; Rodríguez C; Castro L; Garrido E; Domènech E; García-Planella E; Gisbert JP
    Am J Gastroenterol; 2017 Jan; 112(1):120-131. PubMed ID: 27958281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
    Targownik LE; Benchimol EI; Bernstein CN; Singh H; Lix L; Tennakoon A; Leung S; Aviña A; Coward S; Jones J; Kaplan G; Murthy SK; Nguyen GC; Peña-Sánchez JN
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1788-1798.e2. PubMed ID: 30448599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD.
    Click B; Barnes EL; Cohen BL; Sands BE; Hanson JS; Rubin DT; Dubinsky MC; Regueiro M; Gazis D; Crawford JM; Long MD
    BMC Gastroenterol; 2022 Feb; 22(1):71. PubMed ID: 35183108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy.
    Chen C; Hartzema AG; Xiao H; Wei YJ; Chaudhry N; Ewelukwa O; Glover SC; Zimmermann EM
    Inflamm Bowel Dis; 2019 Jul; 25(8):1417-1427. PubMed ID: 30839057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
    Burisch J; Jess T; Egeberg A
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease and bipolar disorder: A population-based cross-sectional study.
    Kao LT; Lin HC; Lee HC
    J Affect Disord; 2019 Mar; 247():120-124. PubMed ID: 30660021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
    Busingye D; Pollack A; Chidwick K
    PLoS One; 2021; 16(5):e0252458. PubMed ID: 34043730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease.
    Zelinkova Z; Bultman E; Vogelaar L; Bouziane C; Kuipers EJ; van der Woude CJ
    World J Gastroenterol; 2012 Dec; 18(47):6967-73. PubMed ID: 23322995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry.
    Hernández-Camba A; Arranz L; Vera I; Carpio D; Calafat M; Lucendo AJ; Taxonera C; Marín S; Garcia MJ; Marín GS; Rodríguez ES; Carbajo AY; De Castro ML; Iborra M; Martin-Cardona A; Rodríguez-Lago I; Busquets D; Bertoletti F; Ausín MS; Tardillo C; Malaves JH; Bujanda L; Castaño A; Domènech E; Ramos L; ;
    Dig Liver Dis; 2022 May; 54(5):635-641. PubMed ID: 34862115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.
    Müller KE; Lakatos PL; Arató A; Kovács JB; Várkonyi Á; Szűcs D; Szakos E; Sólyom E; Kovács M; Polgár M; Nemes É; Guthy I; Tokodi I; Tóth G; Horváth Á; Tárnok A; Csoszánszki N; Balogh M; Vass N; Bódi P; Dezsőfi A; Gárdos L; Micskey E; Papp M; Cseh Á; Szabó D; Vörös P; Veres G;
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):576-82. PubMed ID: 23820399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease.
    Ungaro R; Chang HL; Côté-Daigneault J; Mehandru S; Atreja A; Colombel JF
    Am J Gastroenterol; 2016 Oct; 111(10):1416-1423. PubMed ID: 27296939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity?
    Jeuring SF; van den Heuvel TR; Zeegers MP; Hameeteman WH; Romberg-Camps MJ; Oostenbrug LE; Masclee AA; Jonkers DM; Pierik MJ
    Inflamm Bowel Dis; 2016 Jun; 22(6):1425-34. PubMed ID: 26933752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.